TriSalus Life Sciences, Inc
Price
FilingsNewest: 8-K, Other eventsSep 22 →Insiders6 insiders bought $3.6M in 12 open-market buys. 5 insiders sold $135,808, 0 of 15 sales on a 10b5-1 plan.→HoldersFirst Light 10.7%BlackRock 4.3%Nantahala 3.3%→Financing →PeersClosest companies: IMNM, PMVP, TPST→
From the filings
Figures
- Revenue
- $45.1Mlast 12 months
- Net income
- −$28.2Mlast 12 months
- Operating cash flow
- −$20.0Mlast 12 months
- Cash and equivalents
- $46.3Mat the last balance sheet
- Total debt
- $33.1Mat the last balance sheet
- Shares outstanding
- 61.5M shareson issue